Voloridge Investment Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9M | Sell |
243,601
-216,827
| -47% | -$10.6M | 0.04% | 493 |
|
|
2025
Q1 | $23.5M | Sell |
460,428
-107,936
| -19% | -$5.5M | 0.09% | 311 |
|
|
2024
Q4 | $25.7M | Sell |
568,364
-92,168
| -14% | -$4.16M | 0.09% | 283 |
|
|
2024
Q3 | $24.5M | Sell |
660,532
-122,530
| -16% | -$4.55M | 0.09% | 322 |
|
|
2024
Q2 | $23.9M | Buy |
783,062
+23,681
| +3% | +$724K | 0.09% | 311 |
|
|
2024
Q1 | $22.1M | Sell |
759,381
-60,365
| -7% | -$1.76M | 0.08% | 304 |
|
|
2023
Q4 | $22.6M | Buy |
819,746
+646,513
| +373% | +$17.8M | 0.09% | 292 |
|
|
2023
Q3 | $3.88M | Buy |
+173,233
| New | +$3.88M | 0.02% | 728 |
|
|
2022
Q4 | – | Sell |
-102,299
| Closed | -$5.14M | – | 1600 |
|
|
2022
Q3 | $5.14M | Buy |
+102,299
| New | +$5.14M | 0.03% | 645 |
|
|
2022
Q1 | – | Sell |
-19,226
| Closed | -$766K | – | 1647 |
|
|
2021
Q4 | $766K | Buy |
+19,226
| New | +$766K | ﹤0.01% | 1331 |
|
|
2021
Q3 | – | Sell |
-23,040
| Closed | -$974K | – | 1824 |
|
|
2021
Q2 | $974K | Sell |
23,040
-31,051
| -57% | -$1.31M | 0.01% | 1261 |
|
|
2021
Q1 | $2.56M | Buy |
+54,091
| New | +$2.56M | 0.02% | 735 |
|
|
2020
Q2 | – | Sell |
-30,186
| Closed | -$1.35M | – | 1450 |
|
|
2020
Q1 | $1.35M | Sell |
30,186
-76,883
| -72% | -$3.43M | 0.04% | 437 |
|
|
2019
Q4 | $5.14M | Buy |
+107,069
| New | +$5.14M | 0.1% | 255 |
|
|
2019
Q1 | – | Sell |
-12,461
| Closed | -$428K | – | 1035 |
|
|
2018
Q4 | $428K | Buy |
+12,461
| New | +$428K | 0.02% | 345 |
|
|
2015
Q4 | – | Sell |
-24,503
| Closed | -$654K | – | 282 |
|
|
2015
Q3 | $654K | Buy |
+24,503
| New | +$654K | 0.03% | 241 |
|
|
2015
Q2 | – | Sell |
-121,315
| Closed | -$7.38M | – | 372 |
|
|
2015
Q1 | $7.38M | Buy |
+121,315
| New | +$7.38M | 0.36% | 85 |
|